Brent Zanke - Publications

Affiliations: 
University of Toronto, Toronto, ON, Canada 
Area:
Neuroscience Biology, Molecular Biology, Animal Physiology Biology

77 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Zeng C, Matsuda K, Jia WH, Chang J, Kweon SS, Xiang YB, Shin A, Jee SH, Kim DH, Zhang B, Cai Q, Guo X, Long J, Wang N, Courtney R, et al. Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk. Gastroenterology. PMID 26965516 DOI: 10.1053/j.gastro.2016.02.076  0.92
2016 Garcia-Albeniz X, Rudolph A, Hutter C, White E, Lin Y, Rosse SA, Figueiredo JC, Harrison TA, Jiao S, Brenner H, Casey G, Hudson TJ, Thornquist M, Le Marchand L, Potter J, ... ... Zanke B, et al. CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk. British Journal of Cancer. PMID 26766742 DOI: 10.1038/bjc.2015.443  0.92
2015 Awh CC, Zanke B. Re: Chew et al.: Genetic testing in persons with age-related macular degeneration and the use of AREDS supplements: to test or not to test? (Ophthalmology 2015;122:212-5). Ophthalmology. 122: e62-3. PMID 26398061 DOI: 10.1016/j.ophtha.2015.03.028  0.92
2015 Awh CC, Zanke BW. Reply: To PMID 25200399. Ophthalmology. 122: e59. PMID 26398056 DOI: 10.1016/j.ophtha.2015.02.039  0.92
2015 Lemire M, Zaidi SH, Zanke BW, Gallinger S, Hudson TJ, Cleary SP. The effect of 5-fluorouracil/leucovorin chemotherapy on CpG methylation, or the confounding role of leukocyte heterogeneity: An illustration. Genomics. PMID 26368860 DOI: 10.1016/j.ygeno.2015.09.003  0.92
2015 Awh CC, Zanke BW. Re: Chew et al.: No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38 (Ophthalmology 2014;121:2173-80). Ophthalmology. 122: e46. PMID 26210598 DOI: 10.1016/j.ophtha.2014.12.042  0.92
2015 Khalili H, Gong J, Brenner H, Austin TR, Hutter CM, Baba Y, Baron JA, Berndt SI, Bézieau S, Caan B, Campbell PT, Chang-Claude J, Chanock SJ, Chen C, Hsu L, ... ... Zanke BW, et al. Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer. Carcinogenesis. PMID 26071399 DOI: 10.1093/carcin/bgv086  0.92
2015 Nan H, Hutter CM, Lin Y, Jacobs EJ, Ulrich CM, White E, Baron JA, Berndt SI, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chang-Claude J, ... ... Zanke BW, et al. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. Jama. 313: 1133-42. PMID 25781442 DOI: 10.1001/jama.2015.1815  0.92
2015 Lemire M, Zaidi SH, Ban M, Ge B, Aïssi D, Germain M, Kassam I, Wang M, Zanke BW, Gagnon F, Morange PE, Trégouët DA, Wells PS, Sawcer S, Gallinger S, et al. Long-range epigenetic regulation is conferred by genetic variation located at thousands of independent loci. Nature Communications. 6: 6326. PMID 25716334 DOI: 10.1038/ncomms7326  0.92
2015 Awh CC, Hawken S, Zanke BW. Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study. Ophthalmology. 122: 162-9. PMID 25200399 DOI: 10.1016/j.ophtha.2014.07.049  0.92
2015 Bryant A, Sheppard D, Sabloff M, Delbaere M, Maze R, Allan D, Atkins H, Bence-Bruckler I, Faught C, Huebsch L, Tay J, Zanke B, Bredeson C. A single-institution analysis of the utility of pre-induction ejection fraction measurement in patients newly diagnosed with acute myeloid leukemia. Leukemia & Lymphoma. 56: 135-40. PMID 24913512 DOI: 10.3109/10428194.2014.883072  0.92
2014 Fortin JP, Labbe A, Lemire M, Zanke BW, Hudson TJ, Fertig EJ, Greenwood CM, Hansen KD. Functional normalization of 450k methylation array data improves replication in large cancer studies. Genome Biology. 15: 503. PMID 25599564 DOI: 10.1186/s13059-014-0503-2  0.92
2014 Du M, Zhang X, Hoffmeister M, Schoen RE, Baron JA, Berndt SI, Brenner H, Carlson CS, Casey G, Chan AT, Curtis KR, Duggan D, Gauderman WJ, Giovannucci EL, Gong J, ... ... Zanke BW, et al. No evidence of gene-calcium interactions from genome-wide analysis of colorectal cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2971-6. PMID 25192705 DOI: 10.1158/1055-9965.EPI-14-0893  0.92
2014 Wang H, Burnett T, Kono S, Haiman CA, Iwasaki M, Wilkens LR, Loo LW, Van Den Berg D, Kolonel LN, Henderson BE, Keku TO, Sandler RS, Signorello LB, Blot WJ, Newcomb PA, ... ... Zanke BW, et al. Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A. Nature Communications. 5: 4613. PMID 25105248 DOI: 10.1038/ncomms5613  0.92
2014 Kantor ED, Hutter CM, Minnier J, Berndt SI, Brenner H, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock SJ, Cotterchio M, Du M, Duggan D, ... ... Zanke BW, et al. Gene-environment interaction involving recently identified colorectal cancer susceptibility Loci. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1824-33. PMID 24994789 DOI: 10.1158/1055-9965.EPI-14-0062  0.92
2014 Awh CC, Lane AM, Hawken S, Zanke B, Kim IK. Author reply: To PMID 23972322. Ophthalmology. 121: e39. PMID 24793507 DOI: 10.1016/j.ophtha.2014.02.029  0.92
2014 Figueiredo JC, Hsu L, Hutter CM, Lin Y, Campbell PT, Baron JA, Berndt SI, Jiao S, Casey G, Fortini B, Chan AT, Cotterchio M, Lemire M, Gallinger S, Harrison TA, ... ... Zanke BW, et al. Genome-wide diet-gene interaction analyses for risk of colorectal cancer. Plos Genetics. 10: e1004228. PMID 24743840 DOI: 10.1371/journal.pgen.1004228  0.92
2014 Wilkes MF, Miller DM, Mitchell MD, Zanke B, Petersen MR, Sisk RA, Riemann CD, Foster RE. Investigation of choroidal neovascularization risk alleles in ocular histoplasmosis. Ophthalmology. 121: 1487-8.e1. PMID 24612979 DOI: 10.1016/j.ophtha.2013.01.079  0.92
2014 Peltekova VD, Lemire M, Qazi AM, Zaidi SH, Trinh QM, Bielecki R, Rogers M, Hodgson L, Wang M, D'Souza DJ, Zandi S, Chong T, Kwan JY, Kozak K, De Borja R, ... ... Zanke BW, et al. Identification of genes expressed by immune cells of the colon that are regulated by colorectal cancer-associated variants. International Journal of Cancer. Journal International Du Cancer. 134: 2330-41. PMID 24154973 DOI: 10.1002/ijc.28557  0.92
2014 Cheng I, Kocarnik JM, Dumitrescu L, Lindor NM, Chang-Claude J, Avery CL, Caberto CP, Love SA, Slattery ML, Chan AT, Baron JA, Hindorff LA, Park SL, Schumacher FR, Hoffmeister M, ... ... Zanke BW, et al. Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia. Gut. 63: 800-7. PMID 23935004 DOI: 10.1136/gutjnl-2013-305189  0.92
2013 Hiraki LT, Qu C, Hutter CM, Baron JA, Berndt SI, Bézieau S, Brenner H, Caan BJ, Casey G, Chang-Claude J, Chanock SJ, Conti DV, Duggan D, Fuchs CS, Gallinger S, ... ... Zanke BW, et al. Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 2037-46. PMID 23983240 DOI: 10.1158/1055-9965.EPI-13-0209  0.92
2013 Awh CC, Lane AM, Hawken S, Zanke B, Kim IK. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. Ophthalmology. 120: 2317-23. PMID 23972322 DOI: 10.1016/j.ophtha.2013.07.039  0.92
2013 Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, Gallinger S, Hudson TJ, Weksberg R. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics : Official Journal of the Dna Methylation Society. 8: 203-9. PMID 23314698 DOI: 10.4161/epi.23470  0.92
2013 Peters U, Jiao S, Schumacher FR, Hutter CM, Aragaki AK, Baron JA, Berndt SI, Bézieau S, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, ... ... Zanke BW, et al. Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology. 144: 799-807.e24. PMID 23266556 DOI: 10.1053/j.gastro.2012.12.020  0.92
2013 Dunlop MG, Tenesa A, Farrington SM, Ballereau S, Brewster DH, Koessler T, Pharoah P, Schafmayer C, Hampe J, Völzke H, Chang-Claude J, Hoffmeister M, Brenner H, von Holst S, Picelli S, ... ... Zanke B, et al. Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut. 62: 871-81. PMID 22490517 DOI: 10.1136/gutjnl-2011-300537  0.92
2012 Jiao S, Hsu L, Berndt S, Bézieau S, Brenner H, Buchanan D, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock S, Conti DV, Curtis KR, ... ... Zanke BW, et al. Genome-wide search for gene-gene interactions in colorectal cancer. Plos One. 7: e52535. PMID 23300701 DOI: 10.1371/journal.pone.0052535  0.92
2012 Savio AJ, Lemire M, Mrkonjic M, Gallinger S, Zanke BW, Hudson TJ, Bapat B. MLH1 region polymorphisms show a significant association with CpG island shore methylation in a large cohort of healthy individuals. Plos One. 7: e51531. PMID 23240038 DOI: 10.1371/journal.pone.0051531  0.92
2012 Hutter CM, Chang-Claude J, Slattery ML, Pflugeisen BM, Lin Y, Duggan D, Nan H, Lemire M, Rangrej J, Figueiredo JC, Jiao S, Harrison TA, Liu Y, Chen LS, Stelling DL, ... ... Zanke BW, et al. Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Research. 72: 2036-44. PMID 22367214 DOI: 10.1158/0008-5472.CAN-11-4067  0.92
2012 Peters U, Hutter CM, Hsu L, Schumacher FR, Conti DV, Carlson CS, Edlund CK, Haile RW, Gallinger S, Zanke BW, Lemire M, Rangrej J, Vijayaraghavan R, Chan AT, Hazra A, et al. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Human Genetics. 131: 217-34. PMID 21761138 DOI: 10.1007/s00439-011-1055-0  0.92
2011 Figueiredo JC, Lewinger JP, Song C, Campbell PT, Conti DV, Edlund CK, Duggan DJ, Rangrej J, Lemire M, Hudson T, Zanke B, Cotterchio M, Gallinger S, Jenkins M, Hopper J, et al. Genotype-environment interactions in microsatellite stable/microsatellite instability-low colorectal cancer: results from a genome-wide association study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 758-66. PMID 21357381 DOI: 10.1158/1055-9965.EPI-10-0675  0.92
2011 Awh CC, Zanke B. Applying genetic risk data to clinical practice: A predictive test may help in identifying the risk of developing advanced AMD Retina Today. 78-79.  0.92
2010 Mrkonjic M, Roslin NM, Greenwood CM, Raptis S, Pollett A, Laird PW, Pethe VV, Chiang T, Daftary D, Dicks E, Thibodeau SN, Gallinger S, Parfrey PS, Younghusband HB, Potter JD, ... ... Zanke BW, et al. Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer. Plos One. 5: e13314. PMID 20967208 DOI: 10.1371/journal.pone.0013314  0.92
2010 Elliott KS, Zeggini E, McCarthy MI, Gudmundsson J, Sulem P, Stacey SN, Thorlacius S, Amundadottir L, Grönberg H, Xu J, Gaborieau V, Eeles RA, Neal DE, Donovan JL, Hamdy FC, ... ... Zanke B, et al. Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies. Plos One. 5: e10858. PMID 20526366 DOI: 10.1371/journal.pone.0010858  0.92
2010 Hawken SJ, Greenwood CM, Hudson TJ, Kustra R, McLaughlin J, Yang Q, Zanke BW, Little J. The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer. Human Genetics. 128: 89-101. PMID 20437058 DOI: 10.1007/s00439-010-0828-1  0.92
2010 Zanke B, Hawken S, Carter R, Chow D. A genetic approach to stratification of risk for age-related macular degeneration. Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie. 45: 22-7. PMID 20130705 DOI: 10.3129/i09-209  0.92
2010 Tomlinson IP, Dunlop M, Campbell H, Zanke B, Gallinger S, Hudson T, Koessler T, Pharoah PD, Niittymäki I, Niittymäkix I, Tuupanen S, Tuupanenx S, Aaltonen LA, Hemminki K, Lindblom A, et al. COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. British Journal of Cancer. 102: 447-54. PMID 19920828 DOI: 10.1038/sj.bjc.6605338  0.92
2010 Zanke B. Analysis of major alleles associated with age-related macular degeneration in patients with multifocal choroiditis: Comment Evidence-Based Ophthalmology. 11: 16-17. DOI: 10.1097/IEB.0b013e31819edcaf  0.92
2009 Kerner JF, Cazap E, Yach D, Pierotti MA, Daidone MG, De Blasio P, Geary P, Schacter B, Sant M, Habbema JDF, Sankaranarayanan R, Sutcliffe C, Sutcliffe S, Kaijage JK, Scanlan PA, ... ... Zanke B, et al. Comprehensive cancer control-research & development: Knowing what we do and doing what we know Tumori. 95: 610-622. PMID 19999951  0.92
2009 Labonté L, Li Y, Yang L, Gillingham A, Halpenny M, Giulivi A, Sills T, Evans K, Zanke B, Allan DS. Increased plasma EPO and MIP-1 alpha are associated with recruitment of vascular progenitors but not CD34(+) cells in autologous peripheral blood stem cell grafts. Experimental Hematology. 37: 673-8. PMID 19463769 DOI: 10.1016/j.exphem.2009.02.010  0.92
2009 Mrkonjic M, Chappell E, Pethe VV, Manno M, Daftary D, Greenwood CM, Gallinger S, Zanke BW, Knight JA, Bapat B. Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer. British Journal of Cancer. 100: 1966-74. PMID 19455140 DOI: 10.1038/sj.bjc.6605097  0.92
2009 Zanke B. Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab Evidence-Based Ophthalmology. 10: 210-211. DOI: 10.1097/IEB.0b013e3181b93d80  0.92
2008 Houlston RS, Webb E, Broderick P, Pittman AM, Di Bernardo MC, Lubbe S, Chandler I, Vijayakrishnan J, Sullivan K, Penegar S, Carvajal-Carmona L, Howarth K, Jaeger E, ... ... Zanke BW, et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nature Genetics. 40: 1426-35. PMID 19011631 DOI: 10.1038/ng.262  0.92
2008 Zogopoulos G, Jorgensen C, Bacani J, Montpetit A, Lepage P, Ferretti V, Chad L, Selvarajah S, Zanke B, Hudson TJ, Pawson T, Gallinger S. Germline EPHB2 receptor variants in familial colorectal cancer. Plos One. 3: e2885. PMID 18682749 DOI: 10.1371/journal.pone.0002885  0.92
2008 Tenesa A, Farrington SM, Prendergast JG, Porteous ME, Walker M, Haq N, Barnetson RA, Theodoratou E, Cetnarskyj R, Cartwright N, Semple C, Clark AJ, Reid FJ, Smith LA, Kavoussanakis K, ... ... Zanke BW, et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nature Genetics. 40: 631-7. PMID 18372901 DOI: 10.1038/ng.133  0.92
2007 Zogopoulos G, Ha KC, Naqib F, Moore S, Kim H, Montpetit A, Robidoux F, Laflamme P, Cotterchio M, Greenwood C, Scherer SW, Zanke B, Hudson TJ, Bader GD, Gallinger S. Germ-line DNA copy number variation frequencies in a large North American population. Human Genetics. 122: 345-53. PMID 17638019 DOI: 10.1007/s00439-007-0404-5  0.92
2007 Zanke BW, Greenwood CM, Rangrej J, Kustra R, Tenesa A, Farrington SM, Prendergast J, Olschwang S, Chiang T, Crowdy E, Ferretti V, Laflamme P, Sundararajan S, Roumy S, Olivier JF, et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nature Genetics. 39: 989-94. PMID 17618283 DOI: 10.1038/ng2089  0.92
2005 Dranitsaris G, Johnston M, Poirier S, Schueller T, Milliken D, Green E, Zanke B. Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners. 11: 69-78. PMID 16465719 DOI: 10.1191/1078155205jp155oa  0.92
2005 Dranitsaris G, Evans WK, Milliken D, Zanke B. The impact of practice guidelines and funding policies on the use of new drugs in advanced non-small cell lung cancer. Journal of Evaluation in Clinical Practice. 11: 350-6. PMID 16011647 DOI: 10.1111/j.1365-2753.2005.00546.x  0.92
2004 Listgarten J, Damaraju S, Poulin B, Cook L, Dufour J, Driga A, Mackey J, Wishart D, Greiner R, Zanke B. Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 2725-37. PMID 15102677 DOI: 10.1158/1078-0432.CCR-1115-03  0.92
2003 Listgarten J, Graham K, Damaraju S, Cass C, Mackey J, Zanke B. Clinically validated benchmarking of normalisation techniques for two-colour oligonucleotide spotted microarray slides. Applied Bioinformatics. 2: 219-28. PMID 15130793  0.92
2003 Yee KW, Moore SJ, Midmer M, Zanke BW, Tong F, Hedley D, Minden MD. NKIAMRE, a novel conserved CDC2-related kinase with features of both mitogen-activated protein kinases and cyclin-dependent kinases. Biochemical and Biophysical Research Communications. 308: 784-92. PMID 12927787 DOI: 10.1016/S0006-291X(03)01475-X  0.92
2003 Iscoe N, Bramwell V, Charette M, Oliver T, Zanke B. Liposomal anthracyclines in the management of patients with HIV-positive Kaposi sarcoma Current Oncology. 10: 27-35.  0.92
2002 Damaraju S, Sawyer M, Zanke B. Genomic approaches to clinical drug resistance. Cancer Treatment and Research. 112: 347-72. PMID 12481724  0.92
2002 Crump M, Couban S, Meyer R, Rudinskas L, Zanke B, Gluck S, Maksymiuk A, Hoskins P, Matthews S, Eisenhauer E. Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: a National Cancer Institute of Canada Clinical Trials Group study. Leukemia & Lymphoma. 43: 1581-7. PMID 12400600 DOI: 10.1080/1042819021000002901  0.92
2002 Haq R, Brenton JD, Takahashi M, Finan D, Finkielsztein A, Damaraju S, Rottapel R, Zanke B. Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Research. 62: 5076-82. PMID 12208764  0.92
2002 Ho JM, Nguyen MH, Dierov JK, Badger KM, Beattie BK, Tartaro P, Haq R, Zanke BW, Carroll MP, Barber DL. TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein/Jun kinase (SAPK/JNK), and p38 signaling pathways. Blood. 100: 1438-48. PMID 12149229  0.92
2002 Bayani J, Brenton JD, Macgregor PF, Beheshti B, Albert M, Nallainathan D, Karaskova J, Rosen B, Murphy J, Laframboise S, Zanke B, Squire JA. Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays Cancer Research. 62: 3466-3476. PMID 12067990  0.92
2002 Haq R, Halupa A, Beattie BK, Mason JM, Zanke BW, Barber DL. Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases. The Journal of Biological Chemistry. 277: 17359-66. PMID 11875080 DOI: 10.1074/jbc.M201842200  0.92
2001 Gronda M, Arab S, Iafrate B, Suzuki H, Zanke BW. Hematopoietic protein tyrosine phosphatase suppresses extracellular stimulus-regulated kinase activation Molecular and Cellular Biology. 21: 6851-6858. PMID 11564869 DOI: 10.1128/MCB.21.20.6851-6858.2001  0.92
2001 Tinmouth A, Zanke B, Imrie KR. Fludarabine in alkylator-resistant follicular non-Hodgkin's lymphoma Leukemia and Lymphoma. 41: 137-145. PMID 11342365  0.92
2001 Haq R, Randall S, Midmer M, Yee K, Zanke B. NKIATRE is a novel conserved cdc2-related kinase. Genomics. 71: 131-41. PMID 11161806 DOI: 10.1006/geno.2000.6424  0.92
2000 Curtis JE, Hao Y, Messner HA, Lipton JH, Lowsky R, Quirt IC, Sturgeon JF, Zanke B, Keating A, Minden MD. Acute Myeloblastic Leukemia: Management with High-Dose Cytosine Arabinoside, Daunorubicin and Marrow Transplantation; Malignancy; Current Clinical Practice. Hematology (Amsterdam, Netherlands). 5: 177-187. PMID 11399613  0.92
2000 Jones NL, Islur A, Haq R, Mascarenhas M, Karmali MA, Perdue MH, Zanke BW, Sherman PM. Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family. American Journal of Physiology. Gastrointestinal and Liver Physiology. 278: G811-9. PMID 10801274  0.92
1999 Midmer M, Haq R, Squire JA, Zanke BW. Identification of NKIAMRE, the human homologue to the mitogen-activated protein kinase-/cyclin-dependent kinase-related protein kinase NKIATRE, and its loss in leukemic blasts with chromosome arm 5q deletion Cancer Research. 59: 4069-4074. PMID 10463609  0.92
1999 Collier JD, Zanke B, Moore M, Kessler G, Krajden M, Shepherd F, Heathcote J. No association between hepatitis C and B-cell lymphoma Hepatology. 29: 1259-1261. PMID 10094973  0.92
1998 Haq R, Zanke B. Inhibition of apoptotic signaling pathways in cancer cells as a mechanism of chemotherapy resistance. Cancer Metastasis Reviews. 17: 233-9. PMID 9770120 DOI: 10.1023/A:1006075007857  0.92
1998 Zanke BW, Lee C, Arab S, Tannock IF. Death of tumor cells after intracellular acidification is dependent on stress-activated protein kinases (SAPK/JNK) pathway activation and cannot be inhibited by Bcl-2 expression or interleukin 1β-converting enzyme inhibition Cancer Research. 58: 2801-2808. PMID 9661894  0.92
1997 Kiefer F, Tibbles LA, Lassamt N, Zanke B, Iscove N, Woodgett JR. Novel components of mammalian stress-activated protein kinase cascades Biochemical Society Transactions. 25: 491-498. PMID 9191142  0.92
1996 Kiefer F, Tibbles LA, Anafi M, Janssen A, Zanke BW, Lassam N, Pawson T, Woodgett JR, Iscove NN. HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway Embo Journal. 15: 7013-7025. PMID 9003777  0.92
1996 Zanke BW, Rubie EA, Winnett E, Chan J, Randall S, Parsons M, Boudreau K, McInnis M, Yan M, Templeton DJ, Woodgett JR. Mammalian mitogen-activated protein kinase pathways are regulated through formation of specific kinase-activator complexes. The Journal of Biological Chemistry. 271: 29876-81. PMID 8939929 DOI: 10.1074/jbc.271.47.29876  0.92
1996 Liu FF, Miller N, Levin W, Zanke B, Cooper B, Henry M, Sherar MD, Pintilie M, Hunt JW, Hill RP. The potential role of HSP70 as an indicator of response to radiation and hyperthermia treatments for recurrent breast cancer. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 12: 197-208; discussion . PMID 8926389  0.92
1996 Zanke BW, Boudreau K, Rubie E, Winnett E, Tibbles LA, Zon L, Kyriakis J, Liu FF, Woodgett JR. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat Current Biology. 6: 606-613. PMID 8805279  0.92
1995 Boivin JF, Hutchison GB, Zauber AG, Bernstein L, Davis FG, Michel RP, Zanke B, Tan CTC, Fuller LM, Mauch P, Ultmann JE. Incidence of second cancers in patients treated for hodgkin's disease Journal of the National Cancer Institute. 87: 732-741. PMID 7563150 DOI: 10.1093/jnci/87.10.732  0.92
1994 Zanke B, Squire J, Griesser H, Henry M, Suzuki H, Patterson B, Minden M, Mak TW. A hematopoietic protein tyrosine phosphatase (HePTP) gene that is amplified and overexpressed in myeloid malignancies maps to chromosome 1q32.1 Leukemia. 8: 236-244. PMID 8309248  0.92
1992 Zanke B, Suzuki H, Kishihara K, Mizzen L, Minden M, Pawson A, Mak TW. Cloning and expression of an inducible lymphoid‐specific, protein tyrosine phosphatase (HePTPase) European Journal of Immunology. 22: 235-239. PMID 1530918 DOI: 10.1002/eji.1830220134  0.92
1989 Zanke BW, Rush DN, Jeffery JR, Israels LG. HTLV-1 T cell lymphoma in a cyclosporine-treated renal transplant patient. Transplantation. 48: 695-7. PMID 2799926  0.92
1988 Zanke BW, Johnston JB, Israels LG. Erythremic [corrected] myelosis in chronic lymphocytic leukemia. Cancer. 62: 954-7. PMID 3165688  0.92
Show low-probability matches.